The studies conducted in obese women with PCOS demonstrated a deterioration of glucose tolerance with OCPs administration likely due to a decrease in insulin sensitivity with no change in plasma insulin concentrations [44, 45]. The gene discussed is INS; the disease is polycystic ovary syndrome.